Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
Status: SUSPENDED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Glioma|Hepatocellular Cancer|Squamous Cell Lung Cancer|Pancreatic Cancer|Colon Cancer|Prostate Cancer
Interventions: BIOLOGICAL: Autologous Natural Killer / Natural Killer T Cell Immunotherapy
Sponsor: Envita Medical Center, Inc.